Upregulating hsa-miR-128a Increased the Effects of Pembrolizumab on Laryngeal Cancer Cells via the p53 Pathway
- Type
- Retraction
- Notice date
- 1/13/2024 0:00
- Journal
- BioMed Research International
- Publisher
- Hindawi
- Notice DOI
- 10.1155/2024/9825952
- Original paper DOI
- 10.1155/2021/2342784
Reasons
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Paper Mill
- Unreliable Results and/or Conclusions